Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$355M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$304M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Gilead Sciences
GILD
|
+$239M |
| 5 |
Visa
V
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$388M |
| 2 |
Wells Fargo
WFC
|
+$370M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$295M |
| 4 |
Alibaba
BABA
|
+$234M |
| 5 |
IBM
IBM
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.55% |
| 2 | Healthcare | 5.29% |
| 3 | Financials | 4.23% |
| 4 | Communication Services | 3.53% |
| 5 | Energy | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5851
Kadant
KAI
$3.95B
| $1K | ﹤0.01% |
+12
| New | +$476 |
|
5852
Karyopharm Therapeutics
KPTI
$44.2M
| $1K | ﹤0.01% |
15
-20
| -57% | -$2.21K |
|
5853
CALL
Lumentum
LITE
$65.2B
| $1K | ﹤0.01% |
40
-8,780
| -100% | -$203K |
|
5854
El Pollo Loco
LOCO
$499M
| $1K | ﹤0.01% |
98
-41
| -29% | -$516 |
|
5855
LG Display
LPL
$3.24B
| $1K | ﹤0.01% |
83
-13
| -14% | -$126 |
|
5856
Larimar Therapeutics
LRMR
$436M
| $1K | ﹤0.01% |
12
-700
| -98% | -$55.3K |
|
5857
LSI Industries
LYTS
$913M
| $1K | ﹤0.01% |
+52
| New | +$566 |
|
5858
Medallion Financial
MFIN
$249M
| $1K | ﹤0.01% |
63
+21
| +50% | +$160 |
|
5859
McGrath RentCorp
MGRC
$2.97B
| $1K | ﹤0.01% |
+32
| New | +$786 |
|
5860
Marcus & Millichap
MMI
$1.2B
| $1K | ﹤0.01% |
+35
| New | +$820 |
|
5861
Mercury Systems
MRCY
$6.53B
| $1K | ﹤0.01% |
+27
| New | +$472 |
|
5862
Nathan's Famous
NATH
$403M
| $1K | ﹤0.01% |
+18
| New | +$875 |
|
5863
Neurogene
NGNE
$710M
| $1K | ﹤0.01% |
6
-8
| -57% | -$1.55K |
|
5864
New Mountain Finance
NMFC
$723M
| $1K | ﹤0.01% |
83
+45
| +118% | +$546 |
|
5865
Nuveen Municipal Income
NMI
$130M
| $1K | ﹤0.01% |
100
+74
| +285% | +$918 |
|
5866
Nelnet
NNI
$4.85B
| $1K | ﹤0.01% |
+30
| New | +$1.05K |
|
5867
Northrim BanCorp
NRIM
$591M
| $1K | ﹤0.01% |
+184
| New | +$1.1K |
|
5868
Enviri
NVRI
$630M
| $1K | ﹤0.01% |
184
-3,628
| -95% | -$21K |
|
5869
Quanex
NX
$959M
| $1K | ﹤0.01% |
39
-3,561
| -99% | -$62.8K |
|
5870
OceanFirst Financial
OCFC
$1.92B
| $1K | ﹤0.01% |
+78
| New | +$1.37K |
|
5871
Orion
OEC
$430M
| $1K | ﹤0.01% |
+53
| New | +$667 |
|
5872
Ooma
OOMA
$588M
| $1K | ﹤0.01% |
+218
| New | +$1.39K |
|
5873
Prestige Consumer Healthcare
PBH
$2.58B
| $1K | ﹤0.01% |
21
-50
| -70% | -$2.46K |
|
|
PBPB
5874
DELISTED
Potbelly
PBPB
| $1K | ﹤0.01% |
+55
| New | +$660 |
|
5875
uniQure
QURE
$3.15B
| $1K | ﹤0.01% |
140
-2,164
| -94% | -$32K |
|
Similar funds
Barclays's Q1 2016 Portfolio in Review
As of Q1 2016, Barclays held 6,944 positions worth $65.6B, down 20% from $82.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays withdrew a net $15.2B in Q1 2016, closing 588 positions and reducing 2,924 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $295M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR S&P Pharmaceuticals ETF worth $26M.
- Barclays's largest Q1 2016 buy was State Street SPDR S&P Pharmaceuticals ETF: 650,000 shares worth $26M.
- Barclays added most to KLA in Q1 2016, an estimated $355M increase.
- Barclays's biggest Q1 2016 reduction was Apple, cutting an estimated $388M.
- Barclays fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $295M.
- Barclays's ten largest holdings make up 29% of its $65.6B portfolio in Q1 2016.
- Barclays opened 766 new positions and closed 588 in Q1 2016.
- Barclays's portfolio value fell 20% quarter-over-quarter to $65.6B.
Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.